Search results
Partisan gridlock prevents fixes to Pennsylvania’s voting laws as presidential election looms
The News-Times· 6 days ago“Everyone just really feels how high the stakes are in Pennsylvania, being the largest swing state in the country,” said Lauren Cristella, president and CEO of the Committee ...
Partisan gridlock prevents fixes to Pennsylvania’s voting laws as presidential election looms
KAAL Austin· 6 days ago“Everyone just really feels how high the stakes are in Pennsylvania, being the largest swing state...
Oppenheimer Reiterates Market Perform Rating for Editas Medicine (NASDAQ:EDIT)
ETF DAILY NEWS· 20 hours agoEditas Medicine (NASDAQ:EDIT – Get Free Report)‘s stock had its “market perform” rating restated by research analysts at Oppenheimer in a report issued on Tuesday, Benzinga reports. Oppenheimer ...
Businesses are rushing to use generative AI. Now comes the messy part.
Business Insider· 1 day agoCompanies are often slow and careful when adopting new tech. Generative AI is very different, according to a new Bain survey of corporate America.
CHAMBER: Looking back on the historic Time Theatre
Journal Gazette & Times-Courier· 3 days agoThere is excitement in the air in Mattoon, whether you are for it or cautious about it or just plain confused about what is happening, all of the rehab...
06.18.24 -- ABCs Of ADCs
BioresearchOnline· 2 days agoThe following week, Daiichi Sankyo, Inc. CEO Ken Keller offered the story of a mature and well-resource company’s pivot into the space back when ADCs weren’t yet cool again ...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Position Raised by Perceptive Advisors LLC
ETF DAILY NEWS· 5 days agoPerceptive Advisors LLC increased its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 1.3% in the 4th quarter, according to its most recent filing with the SEC. The institutional ...
Analysts Set CRISPR Therapeutics AG (NASDAQ:CRSP) Target Price at $73.46
ETF DAILY NEWS· 7 days agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has been given an average recommendation of “Hold” by the sixteen analysts that are currently covering the stock, MarketBeat Ratings reports ...
